BESHAR LUKE M
Insider CIK 1192128 · TARA Director · RGNX Director · TRIL Director · OMGA Director · NPSP SVP & CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics, Inc. | A Award deriv | 2026-06-15 | 2026-06-16 | 31,000 | — | $0 | 31,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2024-06-07 | 2024-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 18,118 | — | $0 | 18,118 | SEC↗ |
| TARA Protara Therapeutics, Inc. | P Buy | 2022-06-30 | 2022-07-05 | 10,000 | $3.10 | $31.0K | 198,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 18,118 | — | $0 | 18,118 | SEC↗ |
| TARA Protara Therapeutics, Inc. | P Buy | 2022-03-14 | 2022-03-16 | 10,000 | $4.25 | $42.5K | 188,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | P Buy | 2022-03-10 | 2022-03-14 | 10,000 | $4.46 | $44.6K | 178,000 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 6,666 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 547,656 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 40,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2021-07-29 | 2021-07-30 | 52,941 | — | $0 | 52,941 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2021-06-09 | 2021-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2021-06-04 | 2021-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award | 2020-01-10 | 2020-01-13 | 168,000 | — | $0 | 168,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-06-11 | 12,399 | — | $0 | 12,399 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-06-11 | 6,676 | — | $0 | 6,676 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 6,676 | — | $0 | 6,676 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 12,399 | — | $0 | 12,399 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 10,491 | — | $0 | 10,491 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2019-05-31 | 2019-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-29 | 2018-12-03 | 12,784 | — | $0 | 53,000 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-11-29 | 2018-12-03 | 12,784 | $65.00 | $831.0K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-29 | 2018-12-03 | 12,784 | $3.76 | $48.1K | 12,784 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-27 | 2018-11-28 | 4,687 | — | $0 | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-27 | 2018-11-28 | 883 | — | $0 | 7,292 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-27 | 2018-11-28 | 716 | — | $0 | 65,784 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-27 | 2018-11-28 | 6,250 | — | $0 | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-27 | 2018-11-28 | 6,250 | — | $0 | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-11-27 | 2018-11-28 | 18,786 | $65.03 | $1.22M | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-27 | 2018-11-28 | 716 | $3.76 | $2.7K | 18,786 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-27 | 2018-11-28 | 6,250 | $12.74 | $79.6K | 18,070 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-27 | 2018-11-28 | 6,250 | $18.85 | $117.8K | 11,820 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-27 | 2018-11-28 | 4,687 | $22.00 | $103.1K | 5,570 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-27 | 2018-11-28 | 883 | $49.45 | $43.7K | 883 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-26 | 2018-11-28 | 1,721 | — | $0 | 8,175 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-11-26 | 2018-11-28 | 1,721 | $65.00 | $111.9K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-26 | 2018-11-28 | 1,721 | $49.45 | $85.1K | 1,721 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-20 | 2018-11-21 | 13,500 | — | $0 | 66,500 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-20 | 2018-11-21 | 2,988 | — | $0 | 6,250 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-20 | 2018-11-21 | 4,688 | — | $0 | 4,687 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-20 | 2018-11-21 | 4,688 | $22.00 | $103.1K | 4,688 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-20 | 2018-11-21 | 2,988 | $12.74 | $38.1K | 7,676 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-20 | 2018-11-21 | 13,500 | $3.76 | $50.8K | 21,176 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-11-20 | 2018-11-21 | 21,176 | $60.38 | $1.28M | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-19 | 2018-11-21 | 3,262 | — | $0 | 9,238 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-19 | 2018-11-21 | 6,250 | — | $0 | 6,250 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2018-11-19 | 2018-11-21 | 2,604 | — | $0 | 9,896 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-11-19 | 2018-11-21 | 600 | $62.81 | $37.7K | 600 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-11-19 | 2018-11-21 | 10,916 | $60.26 | $657.8K | 1,200 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-19 | 2018-11-21 | 3,262 | $12.74 | $41.6K | 12,116 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2018-11-19 | 2018-11-21 | 600 | $63.53 | $38.1K | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-19 | 2018-11-21 | 6,250 | $18.85 | $117.8K | 8,854 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2018-11-19 | 2018-11-21 | 2,604 | $49.45 | $128.8K | 2,604 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2018-05-25 | 2018-05-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2017-05-24 | 2017-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2016-06-01 | 2016-06-02 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2015-09-16 | 2015-09-17 | 5,208 | — | $0 | 5,208 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2015-09-16 | 2015-09-22 | 9,375 | — | $0 | 9,375 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 10,905 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 30,615 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 53,089 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 14,844 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 3,594 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 7,665 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 10,531 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | U Tender | 2015-02-21 | 2015-02-24 | 75,201 | $46.00 | $3.46M | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-17 | 2015-02-20 | 859 | $38.27 | $32.9K | 30,615 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-17 | 2015-02-20 | 2,969 | $8.21 | $24.4K | 14,844 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-17 | 2015-02-20 | 3,594 | $8.25 | $29.7K | 3,594 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-17 | 2015-02-20 | 2,969 | $8.21 | $24.4K | 74,342 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-17 | 2015-02-20 | 3,594 | $8.25 | $29.7K | 71,373 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-17 | 2015-02-20 | 859 | $38.27 | $32.9K | 75,201 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-13 | 2015-02-20 | 10,531 | — | $0 | 10,531 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-13 | 2015-02-20 | 10,531 | — | $0 | 72,568 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2015-02-13 | 2015-02-20 | 4,789 | $45.88 | $219.7K | 67,779 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-12 | 2015-02-20 | 3,832 | — | $0 | 7,665 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-02-12 | 2015-02-20 | 10,905 | — | $0 | 10,905 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-12 | 2015-02-20 | 3,832 | — | $0 | 63,464 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2015-02-12 | 2015-02-20 | 1,427 | $45.85 | $65.4K | 62,037 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2015-02-07 | 2015-02-20 | 8,967 | — | $0 | 62,780 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2015-02-07 | 2015-02-20 | 3,148 | $45.85 | $144.3K | 59,632 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | G Gift | 2015-02-06 | 2015-02-09 | 10,000 | — | $0 | 62,780 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-12-17 | 2014-12-19 | 31,852 | — | $0 | 53,089 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-12-17 | 2014-12-19 | 11,500 | — | $0 | 9,189 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-12-17 | 2014-12-19 | 8,906 | — | $0 | 17,813 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-12-17 | 2014-12-19 | 11,500 | $3.34 | $38.4K | 84,280 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-12-17 | 2014-12-19 | 8,906 | $8.21 | $73.1K | 93,186 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-12-17 | 2014-12-19 | 31,852 | $8.23 | $262.1K | 125,038 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2014-12-17 | 2014-12-19 | 52,258 | $35.00 | $1.83M | 72,780 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-11-17 | 2014-11-19 | 4,848 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-11-17 | 2014-11-19 | 31,812 | — | $0 | 20,689 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-11-17 | 2014-11-19 | 10,782 | — | $0 | 7,188 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-11-17 | 2014-11-19 | 31,812 | $3.34 | $106.3K | 109,440 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-11-17 | 2014-11-19 | 10,782 | $8.25 | $89.0K | 120,222 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2014-11-17 | 2014-11-19 | 47,442 | $30.01 | $1.42M | 72,780 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-11-17 | 2014-11-19 | 4,848 | $5.85 | $28.4K | 77,628 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2014-10-31 | 2014-11-04 | 10,000 | $29.00 | $290.0K | 72,780 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2014-10-27 | 2014-10-29 | 30,635 | $26.75 | $819.5K | 82,780 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-08-13 | 2014-08-15 | 51,351 | — | $0 | 23,437 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-08-13 | 2014-08-15 | 2,462 | — | $0 | 4,848 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-08-13 | 2014-08-15 | 2,462 | $5.85 | $14.4K | 62,064 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-08-13 | 2014-08-15 | 51,351 | $3.34 | $171.5K | 113,415 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-02-13 | 2014-02-14 | 10,530 | — | $0 | 21,062 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2014-02-13 | 2014-02-14 | 5,459 | $38.30 | $209.1K | 59,602 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-02-13 | 2014-02-14 | 10,530 | — | $0 | 65,061 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 31,474 | — | $0 | 31,474 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 11,497 | — | $0 | 11,497 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2014-02-07 | 2014-02-11 | 8,967 | — | $0 | 59,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2014-02-07 | 2014-02-11 | 4,649 | $35.13 | $163.3K | 54,531 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-01-08 | 2014-01-09 | 31,588 | — | $0 | 74,788 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-01-08 | 2014-01-09 | 31,588 | $3.34 | $105.5K | 90,768 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2014-01-08 | 2014-01-09 | 31,588 | $35.01 | $1.11M | 59,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-01-07 | 2014-01-09 | 8,625 | — | $0 | 106,376 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-26 | 2013-12-30 | 8,624 | — | $0 | 106,376 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-26 | 2013-12-30 | 29,250 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-26 | 2013-12-30 | 8,624 | $3.34 | $28.8K | 97,054 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-12-26 | 2013-12-30 | 37,874 | $30.02 | $1.14M | 59,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-26 | 2013-12-30 | 29,250 | $5.71 | $167.0K | 88,430 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 39,530 | — | $0 | 17,970 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 20,781 | — | $0 | 26,719 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-12-12 | 2013-12-16 | 60,311 | $24.02 | $1.45M | 59,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 39,530 | $8.25 | $326.1K | 98,710 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 20,781 | $8.21 | $170.6K | 119,491 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-09-20 | 2013-09-24 | 5,000 | — | $0 | 7,310 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-09-20 | 2013-09-24 | 45,000 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-09-20 | 2013-09-24 | 5,000 | $30.05 | $150.3K | 59,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-09-20 | 2013-09-24 | 12,000 | $30.32 | $363.8K | 64,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-09-20 | 2013-09-24 | 19,000 | $30.15 | $572.9K | 76,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-09-20 | 2013-09-24 | 14,000 | $30.43 | $426.0K | 95,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-09-20 | 2013-09-24 | 5,000 | $5.85 | $29.3K | 109,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-09-20 | 2013-09-24 | 45,000 | $5.71 | $256.9K | 104,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-09-16 | 2013-09-17 | 50,000 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-09-16 | 2013-09-17 | 50,000 | $4.05 | $202.5K | 109,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-09-16 | 2013-09-17 | 100 | $28.65 | $2.9K | 59,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-09-16 | 2013-09-17 | 49,900 | $27.89 | $1.39M | 59,280 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-05-09 | 2013-05-13 | 45,150 | — | $0 | 50,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-05-09 | 2013-05-13 | 45,150 | $4.05 | $182.9K | 104,330 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-05-09 | 2013-05-13 | 45,150 | $14.18 | $640.2K | 59,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-29 | 2013-05-01 | 4,850 | — | $0 | 95,150 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-04-29 | 2013-05-01 | 4,850 | $14.00 | $67.9K | 59,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-29 | 2013-05-01 | 4,850 | $4.05 | $19.6K | 64,030 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-10 | 2013-04-10 | 50,000 | — | $0 | 100,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-04-10 | 2013-04-10 | 50,000 | $12.00 | $600.0K | 59,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-10 | 2013-04-10 | 50,000 | $4.05 | $202.5K | 109,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-02-19 | 2013-02-21 | 20,000 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2013-02-19 | 2013-02-21 | 6,870 | $8.01 | $55.0K | 59,180 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-02-19 | 2013-02-21 | 20,000 | — | $0 | 66,050 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-02-13 | 2013-02-15 | 31,592 | — | $0 | 31,592 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-02-13 | 2013-02-15 | 84,941 | — | $0 | 84,941 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2013-02-07 | 2013-02-11 | 3,489 | $8.61 | $30.0K | 46,050 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2013-02-07 | 2013-02-11 | 8,966 | — | $0 | 49,539 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-12-21 | 2012-12-21 | 46,000 | — | $0 | 46,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-02-07 | 2012-02-09 | 47,500 | — | $0 | 47,500 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award | 2012-02-07 | 2012-02-09 | 26,900 | — | $0 | 26,900 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-01-30 | 2012-02-01 | 23,000 | — | $0 | 23,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-01-20 | 2012-02-01 | 14,625 | — | $0 | 14,625 | SEC↗ |